TGA Approval

CYRAMZA ramucirumab 500 mg/50 mL solution for intravenous infusion vial (227352)

ARTG ID

227352

ARTG Name

CYRAMZA ramucirumab 500 mg/50 mL solution for intravenous infusion vial

Sponsor

Eli Lilly Australia Pty Ltd

ARTG Date

July 23, 2015

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

ELI LILLY AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/a1335f7dab10b731cde1e8a9c32b2b75.pdf

https://medical-cdn.nocode.com/drug_tga/be15beca7912b200ddd42e441ccd0887.pdf

Ingredient Name

ramucirumab

Empowering clinical research with data-driven insights and AI-powered tools.

CYRAMZA ramucirumab 500 mg/50 mL solution for intravenous infusion vial (227352) - TGA 批准文号 | MedPath